| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660455A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/31/2006 | EP1527052B1 3-heterocyclyl substituted benzoic acid derivatives |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053107 Antiproliferative agents, angiogenesis inhibitors for treating cancer, eye disorders, diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis; N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide |
| 05/30/2006 | US7053093 Nitrogen compounds such as 1-((3- Phenylimidazo(5,1-a)-isoquinolin-6-yl)carbonyl)piperidine, that bind preferentially to gamma-aminobutyric acid (GABAA) receptors; prophylaxis of nervous system disorders |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/24/2006 | DE10347386B4 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 05/24/2006 | CN1777589A Heteroarylcarbamoylbenzene derivative |
| 05/24/2006 | CN1775761A 2, 4-di (4-aminophenyl)-2, 3-benzodiazine-1-one and its synthesizing method |
| 05/24/2006 | CN1775750A One-step method for synthesizing pyridaben by nucleo philic substitution reaction |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/18/2006 | WO2006034341A3 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106033 Pyrazolopyridines and methods of making and using the same |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045624 Compounds and their uses |
| 05/11/2006 | US20060100250 Biphenyl derivatives and their use as fungicides |
| 05/11/2006 | CA2589106A1 Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases |
| 05/11/2006 | CA2589102A1 Pyridazine compounds and methods for using the compounds to treat inflammatory diseases |
| 05/10/2006 | EP1655301A1 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
| 05/10/2006 | EP1653969A2 Pyrrolo 1,2-b pyridazine derivatives |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/04/2006 | WO2005123692A8 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 05/04/2006 | WO2005049581A8 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651616A2 Pyridazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651615A1 Pyridazinyl- piperazines and their use as histamine h3 receptor ligands |
| 05/03/2006 | EP1651611A2 Benzimidazole c-2 heterocycles as kinase inhibitors |
| 05/02/2006 | US7038073 Synthesis of 2-alkyl amino acids |
| 05/02/2006 | US7037880 Ethylene derivatives and pesticides containing said derivatives |
| 04/26/2006 | EP1650195A1 Method of inhibiting production of osteopontin |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1648874A2 Piperazine derivatives and their use as therapeutic agents |
| 04/26/2006 | CN1764649A Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/19/2006 | EP1463730B1 Pyrazolopyridazine derivatives |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | CN1252066C Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/18/2006 | US7030239 Compounds to treat Alzheimer's disease |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/12/2006 | CN1759103A Water-soluble phenylpyridazine derivative and medicine containing the same |
| 04/11/2006 | US7026479 Process for the production of quinazolines |
| 04/11/2006 | US7026478 Iron catalyzed cross coupling reactions of aromatic compounds |
| 04/06/2006 | WO2006036981A2 Small molecule modulators of cytokine activity |
| 04/06/2006 | US20060073472 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 04/06/2006 | CA2579240A1 Small molecule modulators of cytokine activity |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 03/30/2006 | US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation |
| 03/30/2006 | CA2580845A1 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 03/29/2006 | EP1638945A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/29/2006 | CN1753876A New pyridazin-3(2h)-one derivatives |
| 03/28/2006 | US7019148 Synthesis of irbesartan |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/23/2006 | WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols |
| 03/23/2006 | CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols |
| 03/21/2006 | US7015224 7-Tert-butyl-3-(2-fluorophenyl)-6-(2H-(1,2,4)triazol-3-ylmethoxy)-(1,2,4)triazolo (4,3b) pyridazine for the treatment of anxiety and convulsions |
| 03/16/2006 | WO2006028957A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | WO2006027236A1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 03/16/2006 | US20060058305 Antiproliferative agents such as 3-(3-trifluoromethylphenyl)cinnolin-5-ol |
| 03/16/2006 | CA2578996A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | CA2577861A1 Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/15/2006 | EP1633724A1 Phthalazinone derivatives |
| 03/15/2006 | EP1633723A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | US7012041 Phenylpyridazinones |
| 03/14/2006 | US7011701 n-heterocyclic anthracene-10-one compound |
| 03/09/2006 | US20060052627 Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/09/2006 | US20060052599 HDAC inhibitor |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 03/08/2006 | EP1005460B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/08/2006 | CN1745071A Novel ethylenediamine derivatives |
| 03/08/2006 | CN1745069A Mercaptoimidazoles as CCR2 receptor antagonists |
| 03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/02/2006 | WO2005075437A8 Pyridazinone derivatives and their use as pde4 inhibitors |
| 03/02/2006 | CA2578283A1 Heterocyclic compounds and methods of use |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 02/28/2006 | US7005521 Catalytic compositions and methods for asymmetric allylic alkylation |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/23/2006 | CA2576993A1 Bisaryl-sulfonamides |
| 02/22/2006 | EP1626962A1 Benzamide inhibitors of the p2x7 receptor |
| 02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
| 02/21/2006 | US7001895 Pyridazinones; selective inhibitors of the induced isozyme PGHS-2 (Title) and cyclooxygenase 2 (COX-2); side effect reduction; analgesics; antipyretics; antiinflamation, -arthritic and -carcinogenic agents; rheumatic diseases; |